alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial

A.M. Woltman, M.K. Borg, R.S. Binda, D. Sprengers, B.M.E. von Blomberg-van der Flier, R.J. Scheper, K. Hayashi, N. Nishi, A. Boonstra, R. von der Molen, H.L.A. Janssen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)809-818
JournalAntiviral Therapy
Volume14
Issue number6
DOIs
Publication statusPublished - 2009

Cite this

Woltman, A. M., Borg, M. K., Binda, R. S., Sprengers, D., von Blomberg-van der Flier, B. M. E., Scheper, R. J., ... Janssen, H. L. A. (2009). alpha-Galactosylceramide in chronic hepatitis B infection: results from a randomized placebo-controlled Phase I/II trial. Antiviral Therapy, 14(6), 809-818. https://doi.org/10.3851/IMP1295